Lantheus Holdings, Inc. (LNTH)
Lantheus makes radiopharmaceutical imaging agents and cancer products for hospitals, imaging centers and doctors. It last closed at $101.80 on Nov 17, up 0.08% on the day. The average 12-month price target from 2 analysts is $142.00 (+39.5% from the last close), with a high of $175.00 and a low of $109.00. In the past 30 days there were 4 dark pool prints totaling $16.4M, the largest $11.4M.
Key Stats
Last 12 monthsNot reported for this period.
From LNTH's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 5). Last 12 months adds up the four latest quarters.
Earnings
Full earnings history →Analyst Ratings & Price Targets
Analyst Ratings →Based on 2 analysts who set a price target on LNTH in the past 90 days. The average target is $142.00, with a high of $175.00 and a low of $109.00, compared with the last close of $101.80.
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Oct 13 | Mizuho | Downgrade | Hold | $120 → $109 |
| Sep 25 | Redburn Atlantic | Initiated | Buy | $175 |
| Aug 4 | Truist Securities | Downgrade | Hold | $125 → $102.50 |
| Aug 3 | TD Cowen | Downgrade | Hold | $102.50 |
| Jul 16 | Truist Securities | Maintained | Buy | $125 |
Technical Analysis
The stock is 1% above its 20 day and 1% above its 50 day average. It is 8% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 66), near overbought. The nearest support is the Pivot at $101.78, and the nearest resistance the Pivot R1 at $101.87.
| RSI (14) | 65.79 | Strong, overbought above 70 | Neutral |
| MACD | 0.39 | Above its signal line | Bullish |
| Stochastic | 92.6 | Near the top of its range | Overbought |
| ADX (14) | 16.6 | No clear trend | |
| Williams %R | -4.1 | Oversold below −80, overbought above −20 | Overbought |
| CCI (20) | 126.4 | Oversold below −100, overbought above 100 | Overbought |
| Rate of change | +1.0% | Change over 10 sessions | Bullish |
| ATR (14) | $0.46 | Typical daily range, 0.5% of price |
| RSI (14) | 61.48 | Strong, overbought above 70 | Neutral |
| MACD | 2.55 | Below its signal line | Bearish |
| Stochastic | 75.1 | Middle of its range | Neutral |
| ADX (14) | 33.5 | Trending up | |
| Williams %R | -2.7 | Oversold below −80, overbought above −20 | Overbought |
| CCI (20) | 18.5 | Oversold below −100, overbought above 100 | Neutral |
| Rate of change | +1.6% | Change over 10 sessions | Bullish |
| ATR (14) | $2.89 | Typical daily range, 2.8% of price |
What happened before
See how LNTH did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How LNTH has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2015.
Whale Options Flow
90DNo whale options trades in LNTH in the last 90 days.
Dark Pool
30DLNTH Institutional Ownership
Full report →- ▼168 buying vs 277 selling
- ▼Shares held by funds -2.0%
- ▼Funds holding -45
- ●Superinvestors: 3 added, 3 cut
- ●Put/call not meaningful
| Q3 2026 | This quarter | Last quarter | Change |
|---|---|---|---|
| Funds holding | 439 | 484 | −9.3% |
| In funds' top 10 | 10 | 7 | +42.9% |
| Held by funds | – | – | – |
| New / increased | 56 / 112 | 92 / 155 | −32.0% |
| Reduced / sold out | 185 / 92 | 146 / 35 | +53.0% |
| Put/call ratio | 0.11 | 0.04 | +146.6% |
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether LNTH is in one of them and how their past LNTH trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered LNTH in an article yet. Here's the latest on the wider market.
LNTH Congress Trades
All congress trades →| Person | Type | Amount | Traded | Filed | Delay |
|---|---|---|---|---|---|
| Gilbert CisnerosD · CA | Sell | $1K – $15K | Oct 15, 2026 | Nov 10, 2026 | 26 d |
| Gilbert CisnerosD · CA | Sell (partial) | $1K – $15K | Oct 14, 2026 | Nov 10, 2026 | 27 d |
| Gilbert CisnerosD · CA | Buy | $1K – $15K | Jan 28, 2025 | Feb 12, 2025 | 15 d |
| Gilbert CisnerosD · CA | Buy | $1K – $15K | Jan 13, 2025 | Feb 12, 2025 | 30 d |
| Gilbert CisnerosD · CA | Buy | $1K – $15K | Jan 8, 2025 | Feb 12, 2025 | 35 d |
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
About Lantheus Holdings
Lantheus is a company focused on radiopharmaceuticals, which are medicines that contain small amounts of radioactive material and are used in medical imaging and cancer care. Its products include diagnostic imaging agents that help doctors detect and characterize disease, including an agent for Alzheimer's disease, along with products for cancer care. Lantheus sells mainly to hospitals, independent imaging centers and government facilities, and its products are used by radiologists, oncologists and nuclear medicine physicians. The company is based in Bedford, Massachusetts.
- Headquarters
- Bedford, MA






